CLINICAL_TRIALS
trial_result
· 2019-11-15
Clinical Trial Update: OTR Tablet 40 mg Fed-state Bioequivalence Study [Phase 1]
Summary
Phase 1 bioequivalence study of OTR Tablet 40 mg in fed state has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd | Conditions: Chronic Pain | Phase 1 | Status: COMPLETED | Results posted: 2019-11-15